Related Experiment Video
Updated: Aug 14, 2026

Toeprinting Analysis of Translation Initiation Complex Formation on Mammalian mRNAs
Published on: May 10, 2018
MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function
David T Humphreys1, Belinda J Westman, David I K Martin
1Molecular Genetics Program, Victor Chang Cardiac Research Institute (VCCRI), 384 Victoria Street, Darlinghurst (Sydney) NSW 2010, Australia.
Abstract:
MicroRNAs (miRNAs) repress translation of target mRNAs by interaction with partially mismatched sequences in their 3' UTR. The mechanism by which they act on translation has remained largely obscure. We examined the translation of mRNAs containing four partially mismatched miRNA-binding sites in the 3' UTR in HeLa cells cotransfected with a cognate miRNA. The mRNAs were prepared by in vitro transcription and were engineered to employ different modes of translation initiation. We find that the 5' cap structure and the 3' poly(A) tail are each necessary but not sufficient for full miRNA-mediated repression of mRNA translation. Replacing the cap structure with an internal ribosome entry site from either the cricket paralysis virus or the encephalomyocarditis virus impairs miRNA-mediated repression. Collectively, these results demonstrate that miRNAs interfere with the initiation step of translation and implicate the cap-binding protein eukaryotic initiation factor 4E as a molecular target.
Insights
MicroRNAs (miRNAs) repress mRNA translation by targeting the 5' cap and 3' poly(A) tail. These findings reveal that miRNAs interfere with translation initiation, implicating eukaryotic initiation factor 4E.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression.
- miRNAs primarily function by inhibiting mRNA translation.
- The precise mechanism of miRNA-mediated translational repression remains incompletely understood.
Purpose of the Study:
- To elucidate the mechanism of miRNA-mediated translational repression.
- To investigate the roles of the 5' cap and 3' poly(A) tail in miRNA function.
- To identify molecular targets of miRNA action during translation.
Main Methods:
- In vitro transcription of engineered mRNAs with multiple miRNA-binding sites.
- Transfection of HeLa cells with mRNAs and cognate miRNAs.
- Analysis of mRNA translation efficiency under different initiation conditions.
Main Results:
- Both the 5' cap and 3' poly(A) tail are essential, but not sufficient, for full miRNA repression.
- Replacing the 5' cap with an internal ribosome entry site (IRES) significantly reduced miRNA repression.
- miRNA-mediated repression was impaired when cap-dependent translation initiation was bypassed.
Conclusions:
- MicroRNAs interfere with the initiation step of mRNA translation.
- The 5' cap structure is crucial for efficient miRNA-mediated translational repression.
- Eukaryotic initiation factor 4E (eIF4E) is implicated as a direct or indirect molecular target of miRNA action.
Related Concept Videos
MicroRNAs
MicroRNAs
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

